Global and Chinese epidemiologic study of polycystic ovary syndrome in women of childbearing age, 1990–2021, and projections to 2035: Based on the Global Burden of Disease 2021 study
PLOS One · 2025
DOI: 10.1371/journal.pone.0329090 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Junping Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Medicine, Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Global Burden of Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Healthcare Foundation of New Jersey, Shanghai Key Discipline Construction Project, Shanghai Pudong New Area Health Commission.
Abstract (Originalsprache)
Objective
The aim of this study was to synthesize and analyze the burden of disease of polycystic ovary syndrome (PCOS) in women of reproductive age globally and in China from 1990 to 2021.
Methods
The study utilized data from the Global Burden of Disease 2021 database, which contains detailed epidemiologic information from 204 countries and territories. Incidence, prevalence and disability-adjusted life years (DALYs) of polycystic ovary syndrome (PCOS) were assessed. Bayesian age-period cohort modeling was applied to project trends in the burden of disease up to 2035.
Results
Global trend: the incidence of polycystic ovary syndrome (PCOS) increased slightly from 58.84/100,000 in 1990 to 60.30/100,000 in 2021. there was a significant increase in prevalence of 29.66% and an increase in disability-adjusted life-years (DALYs) of 28.37%. Trends in China: Despite a slight decrease in prevalence (−1.96%), the prevalence of polycystic ovary syndrome (PCOS) and the number of DALYs in China increased substantially by 86.95% and 86.56%, respectively. Sociodemographic impact: Countries with higher sociodemographic indices tend to face a higher burden of PCOS. Future projections: BAPC model projections suggest that the prevalence of PCOS will continue to increase globally and in China through 2035.
Conclusion
These findings highlight the growing public health challenge posed by polycystic ovary syndrome and emphasize the need to strengthen early identification, health management, and lifestyle interventions, especially in areas with high SDI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Traditional Medicine, Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
ORCID-Profile: Xiaodan Zhang
Förderung
- Healthcare Foundation of New Jersey
- Shanghai Key Discipline Construction Project
- Shanghai Pudong New Area Health Commission
- Shanghai Municipal Health Commission Traditional Chinese Medicine Research Project
- Discipline Leader, Pudong New District Health Committee
Zitieren
APA
Liu, J., Cai, Y., Li, J., & Zhang, X. (2025). Global and Chinese epidemiologic study of polycystic ovary syndrome in women of childbearing age, 1990–2021, and projections to 2035: Based on the Global Burden of Disease 2021 study. PLOS One. https://doi.org/10.1371/journal.pone.0329090
Vancouver
Liu J, Cai Y, Li J, Zhang X. Global and Chinese epidemiologic study of polycystic ovary syndrome in women of childbearing age, 1990–2021, and projections to 2035: Based on the Global Burden of Disease 2021 study. PLOS One. 2025. doi:10.1371/journal.pone.0329090
BibTeX
@article{Liu2025,
author = {Liu, Junping and Cai, Yan and Li, Jiaying and Zhang, Xiaodan},
title = {Global and Chinese epidemiologic study of polycystic ovary syndrome in women of childbearing age, 1990–2021, and projections to 2035: Based on the Global Burden of Disease 2021 study},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0329090}
}
EUVIMED